Nanjing Pharmaceutical Group Company Limited (SHA:600713)
China flag China · Delayed Price · Currency is CNY
4.930
-0.040 (-0.80%)
May 28, 2026, 3:00 PM CST

SHA:600713 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,0523,0494,5632,3722,3282,095
Trading Asset Securities
170.2215.28----
Cash & Short-Term Investments
2,2233,2644,5632,3722,3282,095
Cash Growth
-16.00%-28.45%92.39%1.87%11.13%41.32%
Accounts Receivable
21,08716,28915,09816,20919,30415,251
Other Receivables
877.1341.7897.929.7129.2822.86
Receivables
21,96416,33115,19616,23819,33415,274
Inventory
7,0986,9046,2865,7985,7874,518
Other Current Assets
1,1811,9131,7641,6051,8131,571
Total Current Assets
32,46528,41227,80826,01329,26123,458
Property, Plant & Equipment
2,0092,0041,8851,5071,5191,492
Long-Term Investments
271.31269.24283.47237.64206.45254.18
Goodwill
63.2463.2472.1772.1772.1772.17
Other Intangible Assets
200.35209.49215.68218.98245.28268.11
Long-Term Deferred Tax Assets
282.68271.27243.43222.82224.93180.78
Long-Term Deferred Charges
108.7598.2663.0743.3436.8934.24
Other Long-Term Assets
104.21103.18102.7495.5884.69126.24
Total Assets
35,50431,43030,67428,41031,65125,886
Accounts Payable
10,70411,09810,1769,69410,1318,064
Accrued Expenses
376.19335.81369.49363.63438.32379.33
Short-Term Debt
4,9744,7593,7604,5748,4147,036
Current Portion of Long-Term Debt
-195.14900.982,2231,409-
Current Portion of Leases
-82.8979.6376.0471.6878.28
Current Income Taxes Payable
-174.1387.691.48102.89136.01
Current Unearned Revenue
306.74333.99278.67103.57219.1274.78
Other Current Liabilities
6,0701,5421,4411,4411,4981,756
Total Current Liabilities
22,43118,52017,09418,56622,28417,525
Long-Term Debt
4,1134,1465,3392,1182,2222,628
Long-Term Leases
176.76192.07116.18119.02103.23124.4
Long-Term Unearned Revenue
266.1260.79277.62297.06293.17304.61
Long-Term Deferred Tax Liabilities
54.358.0459.0555.4154.2469.9
Total Liabilities
27,04123,17822,88621,15524,95620,652
Common Stock
1,3091,3091,3091,3101,3101,042
Additional Paid-In Capital
2,4582,4542,4662,4602,4291,380
Retained Earnings
3,5503,3752,9732,6112,2171,778
Treasury Stock
-43.71-51.33-20.9-35.9-38.58-
Comprehensive Income & Other
85.2698.5111.2489.7281.98406.6
Total Common Equity
7,3587,1856,8386,4356,0004,606
Minority Interest
1,1061,068949.87819.73695.03627.46
Shareholders' Equity
8,4638,2537,7887,2556,6955,234
Total Liabilities & Equity
35,50431,43030,67428,41031,65125,886
Total Debt
9,2639,37510,1969,11012,2199,867
Net Cash (Debt)
-7,041-6,111-5,634-6,738-9,891-7,772
Net Cash Per Share
-4.69-4.17-4.32-5.19-7.89-7.46
Filing Date Shares Outstanding
1,2841,3091,3091,3101,3101,042
Total Common Shares Outstanding
1,2841,3091,3091,3101,3101,042
Working Capital
10,0349,89110,7147,4476,9785,933
Book Value Per Share
5.735.495.224.914.584.42
Tangible Book Value
7,0946,9126,5506,1445,6824,266
Tangible Book Value Per Share
5.535.285.004.694.344.10
Buildings
-1,4521,4631,1331,1661,046
Machinery
-962.26928.24890.32839.29762.13
Construction In Progress
-349.69237.27130.0880.23153.4
Source: S&P Global Market Intelligence. Standard template. Financial Sources.